XORTX Therapeutics Management
Management criteria checks 4/4
XORTX Therapeutics' CEO is Allen Davidoff, appointed in Jan 2018, has a tenure of 6.42 years. total yearly compensation is $378.44K, comprised of 89.3% salary and 10.7% bonuses, including company stock and options. directly owns 2.34% of the company’s shares, worth $144.77K. The average tenure of the management team and the board of directors is 2.5 years and 3.7 years respectively.
Key information
Allen Davidoff
Chief executive officer
US$378.4k
Total compensation
| CEO salary percentage | 89.3% |
| CEO tenure | 6.4yrs |
| CEO ownership | 2.3% |
| Management average tenure | 2.5yrs |
| Board average tenure | 3.7yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$3m |
| Dec 31 2023 | US$378k | US$338k | -US$2m |
| Sep 30 2023 | n/a | n/a | -US$7m |
| Jun 30 2023 | n/a | n/a | -US$7m |
| Mar 31 2023 | n/a | n/a | -US$7m |
| Dec 31 2022 | US$435k | US$369k | -US$8m |
| Sep 30 2022 | n/a | n/a | US$1m |
| Jun 30 2022 | n/a | n/a | -US$3m |
| Mar 31 2022 | n/a | n/a | -US$2m |
| Jan 01 2022 | n/a | n/a | -US$2m |
| Sep 30 2021 | n/a | n/a | -US$9m |
| Jun 30 2021 | n/a | n/a | -US$3m |
| Mar 31 2021 | n/a | n/a | -US$3m |
| Dec 31 2020 | US$204k | US$154k | -US$1m |
| Sep 30 2020 | n/a | n/a | -US$767k |
| Jun 30 2020 | n/a | n/a | -US$536k |
| Mar 31 2020 | n/a | n/a | -US$362k |
| Dec 31 2019 | US$161k | US$148k | -US$485k |
| Sep 30 2019 | n/a | n/a | -US$444k |
| Jun 30 2019 | n/a | n/a | -US$582k |
| Mar 31 2019 | n/a | n/a | -US$660k |
| Dec 31 2018 | US$194k | US$141k | -US$3m |
Compensation vs Market: Allen's total compensation ($USD378.44K) is below average for companies of similar size in the US market ($USD680.27K).
Compensation vs Earnings: Allen's compensation has been consistent with company performance over the past year.
CEO
Allen Davidoff (64 yo)
6.4yrs
Tenure
US$378,436
Compensation
Dr. Allen Warren Davidoff, Ph.D. is Founder of XORTX Therapeutics Inc. (formerly known as XORTX Pharma Corp.) and has been its Chief Executive Officer and President since January 9, 2018. Dr. Davidoff serv...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 6.4yrs | US$378.44k | 2.34% $ 144.8k | |
| Chief Financial Officer | less than a year | US$76.20k | 0.24% $ 14.8k | |
| Chief Medical Officer | 2.9yrs | US$215.27k | 0% $ 0 | |
| Chief Business Officer | 1.6yrs | US$280.00k | no data | |
| Director of Communications | no data | no data | no data | |
| Director of Corporate Development | 3.8yrs | no data | no data | |
| Consultant of Clinical Operations | 2.1yrs | no data | 0% $ 0 | |
| Corporate Secretary | no data | no data | no data |
2.5yrs
Average Tenure
60.5yo
Average Age
Experienced Management: XRTX's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 6.4yrs | US$378.44k | 2.34% $ 144.8k | |
| Independent Director | 6.4yrs | US$10.87k | 0.24% $ 15.1k | |
| Independent Chair of the Board | 2yrs | US$133.97k | 0.33% $ 20.5k | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Independent Director | 3.1yrs | US$10.43k | 0% $ 0 | |
| Independent Director | 2.5yrs | US$9.76k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | 5.7yrs | no data | no data | |
| Independent Director | less than a year | US$12.90k | 0% $ 0 | |
| Member of Clinical Advisory Board | 5.7yrs | no data | no data | |
| Member of the Clinical Advisory Board | 4.3yrs | no data | no data | |
| Member of the Advisory Board | 2.8yrs | no data | no data |
3.7yrs
Average Tenure
68.5yo
Average Age
Experienced Board: XRTX's board of directors are considered experienced (3.7 years average tenure).